Cleared Traditional

K850812 - EMERGIPACE - EXTERNAL PACEMAKER

K850812 is an FDA 510(k) clearance for EMERGIPACE - EXTERNAL PACEMAKER, manufactured by Life Science Instrumentation, Inc.. The device is a Class 2 Cardiovascular device with product code DRO cleared through the Traditional 510(k) pathway after a 250-day FDA review.

K850812 · Life Science Instrumentation, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1985
Decision
250d
Days
Class 2
Risk

K850812 is an FDA 510(k) clearance for the EMERGIPACE - EXTERNAL PACEMAKER. Classified as Pacemaker, Cardiac, External Transcutaneous (non-invasive) (product code DRO), Class II - Special Controls.

Submitted by Life Science Instrumentation, Inc. (Portland, US). The FDA issued a Cleared decision on November 5, 1985 after a review of 250 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.5550 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Life Science Instrumentation, Inc. devices

FDA 510(k) Submission Details - K850812

510(k) Number K850812 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 28, 1985
Decision Date November 05, 1985
Days to Decision 250 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
125d slower than avg
Panel avg: 125d · This submission: 250d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DRO Device Classification - Class 2, Special Controls

Product Code DRO Pacemaker, Cardiac, External Transcutaneous (non-invasive)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.5550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRO Pacemaker, Cardiac, External Transcutaneous (non-invasive)

All 40
Devices cleared under the same product code (DRO) and FDA review panel - the closest regulatory comparables to K850812.
AMI CARDIO-PAD
K860283 · Andover Medical, Inc. · Mar 1986
AMENDMENT LIFEPAK 8, NPN 052
K854117 · Physio-Control Corp. · Jan 1986
LIFEPAK 8 MODIFICATION
K853732 · Physio-Control Corp. · Dec 1985
PACEPAC
K852958 · Medical Data Electronics · Oct 1985
AMENDMENT LIFEPAK 200, NPN 046
K851247 · Physio-Control Corp. · Apr 1985
AMENDMENT LIFEPAK 100, NPN 045
K851248 · Physio-Control Corp. · Apr 1985